Tsopanoglou, Nikos,Maragoudakis, Michael,Strande, Jennifer,Gartaganis, Sotirios,Siablis, Dimitrios,Vinores, Ann Louise
申请号：
AU2015202449
公开号：
AU2015202449A1
申请日:
2015.05.07
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
#$%^&*AU2015202449A120150528.pdf#####ABSTRACT The present invention relates to parstatin peptides, compositions comprising parstatin peptides and their use in the treatment of various disorders, including angiogenesis-related diseases, ocular neovascularisation and related disease states, ischernia- reperfusion injury and myocardial-related disease states, and renal disorders.Figure 1 A Control bFGF VIEGF (ai)(lO0nmoles) (ifl0nmoles) parstatin bFGF VEGF (1-41) + + (10nmoles) parstatin (1-41) parstatin (1-41) 130 20 CO-40 M** -01 p arst I p arstO -1- - + - - + b FGF -i A_+-I + -VE GF 4 - --- +- ±_ 1135
